Wenjian Wang
- Nephrology top 1%
- Renal Diseases and Glomerulopathies 24
- Chronic Kidney Disease and Diabetes 13
- Dialysis and Renal Disease Management 6
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Clinical Biochemistry top 5%
- Molecular Biology top 10%
-
- Electromagnetic wave absorption materials 10
- Metamaterials and Metasurfaces Applications 7
-
- Advanced Antenna and Metasurface Technologies 10
-
- Lipid metabolism and disorders 8
- Co-authors
- Xinling LiangShuangxin LiuFarhad R. DaneshBenny Hung‐Junn ChangPaul T. SchumackerJianyin LongPaul A. OverbeekSandra B. Haudek
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wenjian Wang
126 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 125
- Nephrology 506
- Cancer Research 383
- Clinical Biochemistry 147
- Molecular Biology 1.3k
- Complementary and alternative medicine 144
Countries citing papers authored by Wenjian Wang
This map shows the geographic impact of Wenjian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjian Wang more than expected).
Fields of papers citing papers by Wenjian Wang
This network shows the impact of papers produced by Wenjian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjian Wang. The network helps show where Wenjian Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjian Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 9 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 28 | |
| 12 | 2023 | 23 | |
| 13 | 2023 | 10 | |
| 14 | 2023 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2020 | 2 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 12 | |
| 19 | Effect of ligustrazine on Th1/Th2 imbalance in asthmatic rats | 2004 | 1 |
| 20 | Effect of Crenulatin on Apoptosis of Rats Pulmonary Microvascular Endothelial Cells in Vitro | 2004 | 1 |
About Wenjian Wang
Wenjian Wang is a scholar working on Nephrology, Complementary and alternative medicine and General Engineering, having authored 132 papers that have together received 2.7k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (24 papers), Chronic Kidney Disease and Diabetes (13 papers), Electromagnetic wave absorption materials (10 papers), Advanced Antenna and Metasurface Technologies (10 papers), Lipid metabolism and disorders (8 papers), MicroRNA in disease regulation (7 papers), Metamaterials and Metasurfaces Applications (7 papers) and Dialysis and Renal Disease Management (6 papers). The work is most often cited by research in Nephrology (506 citations), Cancer Research (383 citations) and Clinical Biochemistry (147 citations). Wenjian Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xinling Liang, Shuangxin Liu, Farhad R. Danesh, Benny Hung‐Junn Chang, Paul T. Schumacker, Jianyin Long, Paul A. Overbeek, Sandra B. Haudek, JinRong Wang and Yin Wang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.